Pain Management for Degenerative Disc Disease

First-Line Pharmacological Treatment

• The American Society of Anesthesiologists and the British Medical Journal recommend initial treatment for painful degenerative disc disease to be acetaminophen (paracetamol) in doses of up to 4 g daily, with ibuprofen as a substitute at a dose of 1.2 g daily if acetaminophen fails to provide adequate relief 1, 2
• For insufficient relief with ibuprofen alone, options include increasing ibuprofen to 2.4 g daily, adding acetaminophen to ibuprofen, or switching to alternative NSAIDs such as diclofenac or naproxen 2

Non-Pharmacological Approaches

• The Anesthesiology society recommends physical therapy focusing on core strengthening and flexibility exercises as a cornerstone of treatment, and conventional radiofrequency ablation of the medial branch nerves for persistent facet-related low back pain when previous diagnostic or therapeutic injections have provided temporary relief 1
• Acupuncture may be considered as an adjunct to conventional therapy for nonspecific low back pain, according to the Anesthesiology society 1

Important Caveats and Pitfalls

• The Anesthesiology society advises against chemical denervation for routine care of chronic non-cancer pain, and the British Medical Journal recommends regular monitoring for NSAID-related adverse effects, particularly gastrointestinal and cardiovascular complications 1, 2
• The British Medical Journal suggests considering gastroprotective agents in patients at high risk for NSAID-induced gastrointestinal complications 2

Surgical Considerations

• The Journal of Neurosurgery and Praxis Medical Insights recommend surgical intervention only after at least 6 months of comprehensive conservative management has failed to provide adequate relief, with cervical arthroplasty as an alternative to fusion for cervical degenerative disc disease in selected patients 4, 5, 6

Neuromodulators for Neuropathic Pain Components

• The Clinical Gastroenterology and Hepatology journal recommends tricyclic antidepressants and serotonin-norepinephrine reuptake inhibitors as beneficial for chronic pain with neuropathic features, starting at low doses and titrating to maximum doses 3